KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Other Non Operating Income (2018 - 2025)

Neogenomics (NEO) has disclosed Other Non Operating Income for 8 consecutive years, with $84000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income rose 119.49% year-over-year to $84000.0, compared with a TTM value of $296000.0 through Dec 2025, up 178.1%, and an annual FY2025 reading of $296000.0, up 178.1% over the prior year.
  • Other Non Operating Income was $84000.0 for Q4 2025 at Neogenomics, up from -$335000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $4.1 million in Q4 2021 and bottomed at -$4.9 million in Q1 2021.
  • Average Other Non Operating Income over 5 years is -$7550.0, with a median of $45000.0 recorded in 2022.
  • The sharpest move saw Other Non Operating Income plummeted 2276.68% in 2021, then skyrocketed 24200.0% in 2025.
  • Year by year, Other Non Operating Income stood at $4.1 million in 2021, then crashed by 100.02% to -$1000.0 in 2022, then surged by 12500.0% to $124000.0 in 2023, then tumbled by 447.58% to -$431000.0 in 2024, then skyrocketed by 119.49% to $84000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for NEO at $84000.0 in Q4 2025, -$335000.0 in Q3 2025, and $482000.0 in Q2 2025.